Mainly caused by 'volatility' on the drop. I just want to be clear... I was speaking about short term, and not long term relevance. Earlier I was saying I prefer to go into stocks, particularly biotechs that have at least 1 Yr+ cash to off set cash burn of 1 year. My rule of that is based on relationship to short term trading. I'm a short term trader... Very short term. I just emphasize that the 1 year rule of cash on the books for companies is a good rule. It substantially reduces the risk of any near term sudden surprises of 'cash raising stock offerings', which usually will crash a stock, even at over sold levels (such as STEM & AKBA as recent examples).
But my view is that AKAO is likely safe using the 1 year of cash rule.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.